Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cellsJun Shimizu, Tatsuo Shioda, Yoshihiro Samune et al.|Scientific Reports|2022Cited by 48
The potential of COVID-19 patients’ sera to cause antibody-dependent enhancement of infection and IL-6 productionJun Shimizu, Tatsuo Shioda, Tadahiro Sasaki et al.|Scientific Reports|2021Cited by 25
Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cellsJun Shimizu, Tatsuo Shioda, Tadahiro Sasaki et al.|Scientific Reports|2023Cited by 0
Establishment and Evaluation of Human iPS Cell‐Derived Myeloid Cell Lines Susceptible to SARS‐CoV‐2Takayuki Hishiki, Kazuo Miyazaki, Yuka Yoshimura et al.|Microbiology and Immunology|2026Cited by 0